A phase Ib study of nivolumab in patients with autoimmune disorders and advanced malignancies (AIM-NIVO)

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2020
This article has no abstract
Epistemonikos ID: 7809c420a1d7fa5917f5c231b09c0634165eb90e
First added on: Feb 12, 2025